International Health to Offer Provista's Breast Cancer Test in UK, Ireland | GenomeWeb
NEW YORK (GenomeWeb News) – Provista Life Sciences said today that International Health Technology will offer its early-stage breast cancer detection test in the United Kingdom and in Ireland.
 
Under the license agreement, IHT will offer the blood-based Biomarker Translation Test in its BreastHealth UK clinic this summer. The company said it plans to expand the availability of the test to other European Union countries sometime later, but did not provide further details on its timeline.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.